Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€21.57
29.07.22
-
29.08.22
-15.90%
30.08.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€56.99
29.07.22
-
29.08.22
3.00%
04.08.22

Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€11.58
29.07.22
-
29.07.23
-15.51%
06.08.22

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.22
29.07.22
-
29.07.23
-31.85%
30.07.23

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€4.11
28.07.22
-
28.07.23
35.16%
14.05.23

buy
Nanorepro AG

Start price
Target price
Perf. (%)
€3.97
27.07.22
€15.00
27.08.22
-14.12%
28.08.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Very high dividend yield expected
Top 10 in its market
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€9.83
26.07.22
-
26.08.22
0.52%
27.08.22

buy
Evotec SE

Start price
Target price
Perf. (%)
€25.69
26.07.22
-
26.08.22
-11.44%
27.08.22

buy
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€11.02
26.07.22
-
26.07.23
-70.93%
09.04.23

Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€8.77
25.07.22
-
25.07.23
11.60%
07.08.22

Chimerix Inc.

Start price
Target price
Perf. (%)
€2.29
25.07.22
-
25.07.23
17.71%
07.08.22

buy
Syndax Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€20.60
25.07.22
-
25.07.23
-7.28%
26.07.23

Could be worthwhile Investment >10% per year
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€7.52
25.07.22
-
21.03.23
-16.22%
22.03.23

buy
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€8.56
25.07.22
€12.50
25.07.23
26.95%
26.07.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€9.55
25.07.22
€20.00
31.12.24
-75.71%
08.05.23

Could be very worthwhile Investment >20% year
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.16
24.07.22
-
24.07.23
-2.64%
04.09.22

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.54
24.07.22
-
24.07.23
-3.78%
15.10.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€56.97
22.07.22
-
22.08.22
-0.18%
29.07.22

buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€6.60
22.07.22
-
22.08.22
-
22.07.22

Valneva SE

Start price
Target price
Perf. (%)
€9.82
21.07.22
-
21.07.23
-30.16%
22.07.23

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.37
21.07.22
€5.30
21.07.23
-21.42%
11.03.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.65
21.07.22
€0.60
21.07.23
-46.97%
19.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€0.99
21.07.22
-
21.07.23
-53.25%
14.05.23

Bayer AG

Start price
Target price
Perf. (%)
€58.79
20.07.22
-
20.08.22
-2.91%
22.07.22

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques